Printer Friendly

U.S. treatment guidelines: new version, October 2005.

The October 6, 2005 guidelines have relatively few changes, but they are important for some patients.

For those beginning antiretrovirals, the guidelines now say that the combination of an NNRTI + didanosine plus tenofovir should not be used, due to virologic failure and development of resistance. And the guidelines do not recommend ritonavir-boosted tipranavir in treatment-naive patients, due to the lack of clinical-trial data.

For experienced patients, "This section has been updated to redefine the goal of antiretroviral therapy in the management of treatment-experienced patients with virologic failure and to review the role of more potent ritonavir-boosted protease inhibitors such as tipranavir with or without enfuvirtide in these patients."

Much of the guidelines material is presented in a series of tables. The second page, titled "What's New in the Document," also notes the tables that have been changed.

This and other U.S. government guidelines are available at http://www.aidsinfo.nih.gov/guidelines/
COPYRIGHT 2005 John S. James
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:AIDS Treatment News
Date:Sep 30, 2005
Words:153
Previous Article:Major U.S. treatment-access problems likely: inadequate political response.
Next Article:New California law: insurers cannot deny organ transplants solely because of HIV.
Topics:


Related Articles
HIV's potent cocktail.
Obtaining the New HIV Treatment Guidelines.
FTC (Emtriva[TM]) approved.
Revised U.S. Adult and Adolescent Antiretroviral Treatment Guidelines; also Revised Pediatric Guidelines.
New treatment guidelines published October 29.
If the condom breaks: new U.S. guidelines for nonoccupational exposure to HIV.
Adult HIV treatment guidelines updated.
Research on postexposure prophylaxis for HIV.
HAART at 10--a CFA timeline.
U.S. guidelines: adult/adolescent revision published October 10, 2006; perinatal guidelines October 12; pediatric guidelines October 26.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters